Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
1	NRAS(0.0%)	exon4,c.437C>T,p.A146V	0.0004116	0.001733	8857|4	3144|5	0.00060	24957|15	1	115252203	115252203	G	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				47	0.0
1	NRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0006851	0.0006057	8824|14	3147|3	0.00488	24286|119	1	115252204	115252204	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				49	0.0
1	NRAS(0.0%)	exon4,c.436G>C,p.A146P	0.000203	0.0004432	8824|5	3147|0	0.00197	24286|48	1	115252204	115252204	C	G	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>C	p.Ala146Pro	missense_variant				58	0.0
1	NRAS(0.0%)	exon4,c.436G>A,p.A146T	0.0003449	0.0008401	8824|3	3147|2	0.00086	24286|21	1	115252204	115252204	C	T	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				34	0.0
1	NRAS(0.1%)	exon3,c.182A>G,p.Q61R	0.0008543	0.0007239	5010|6	1774|0	0.00059	13655|8	1	115256529	115256530	T	C	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.182A>G	p.Gln61Arg	missense_variant	Pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|B-cell_chronic_lymphocytic_leukemia|Large_congenital_melanocytic_nevus|Thyroid_cancer,_nonmedullary,_2|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Epidermal_nevus|Epidermal_nevus_syndrome|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Neurocutaneous_melanocytosis|Glioblastoma|Malignant_neoplasm_of_body_of_uterus|not_provided	26	0.0
1	NRAS(0.1%)	exon3,c.181C>A,p.Q61K	0.0005435	0.0007362	4999|9	1766|2	0.00341	13753|47	1	115256530	115256530	G	T	base_qual,clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.181C>A	p.Gln61Lys	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Vascular_Tumors_Including_Pyogenic_Granuloma|Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|Neuroblastoma|B-cell_chronic_lymphocytic_leukemia|Large_congenital_melanocytic_nevus|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Neurocutaneous_melanocytosis|Glioblastoma|Rasopathy|Malignant_neoplasm_of_body_of_uterus|Ras_Inhibitor_response|not_provided	37	0.0
1	NRAS(0.0%)	exon3,c.176C>G,p.A59G	0.0003542	0.0007632	4689|3	1660|0	0.00128	12463|16	1	115256535	115256535	G	C	base_qual,clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.176C>G	p.Ala59Gly	missense_variant				58	0.0
1	NRAS(0.0%)	exon3,c.176C>A,p.A59D	0.0002673	0.0007688	4689|7	1660|2	0.00368	12463|46	1	115256535	115256535	G	T	base_qual,clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.176C>A	p.Ala59Asp	missense_variant	Likely_pathogenic		Anemia|Noonan_syndrome	26	0.0
1	NRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0007046	0.00219	4663|3	1653|2	0.00032	12592|4	1	115256536	115256536	C	T	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.175G>A	p.Ala59Thr	missense_variant	Likely_pathogenic		not_provided	37	0.0
1	NRAS(0.1%)	exon2,c.38G>T,p.G13V	0.0005374	0.0004111	9056|14	3455|2	0.00405	23610|96	1	115258744	115258745	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Neoplasm|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome	42	0.0
1	NRAS(0.1%)	exon2,c.38G>A,p.G13D	0.001098	0.0004102	9056|10	3455|0	0.00093	23610|22	1	115258744	115258745	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>A	p.Gly13Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|RAS-associated_autoimmune_leukoproliferative_disorder|Myelodysplastic_syndrome|Acute_megakaryoblastic_leukemia_in_down_syndrome|not_provided	33	0.0
1	NRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0002412	0.0006981	9062|15	3448|4	0.00712	23831|171	1	115258745	115258745	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	28	0.0
1	NRAS(0.0%)	exon2,c.35G>T,p.G12V	0.0002363	0.001248	9034|7	3413|7	0.00535	23417|126	1	115258747	115258748	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.35G>T	p.Gly12Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	37	0.0
1	NRAS(0.0%)	exon2,c.35G>C,p.G12A	0.000208	0.0004164	9034|3	3413|3	0.00068	23417|16	1	115258747	115258748	C	G	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.35G>C	p.Gly12Ala	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(2),Uncertain_significance(1)	Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|Myelodysplastic_syndrome_progressed_to_acute_myeloid_leukemia|not_provided	52	0.0
1	NRAS(0.0%)	exon2,c.34G>T,p.G12C	0.0004639	0.0004182	8954|15	3387|5	0.00498	23595|118	1	115258748	115258748	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.34G>T	p.Gly12Cys	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	44	0.0
	SPTA1(47.1%)	exon20,c.2874G>A,p.L958=	0.471	0.101	66|55	12|0	0.46377	74|64	1	158626378	158626378	C	T	germline	SPTA1	NM_003126.4	20	c.2874G>A	p.Leu958=	synonymous_variant	Benign		Hereditary_pyropoikilocytosis|Elliptocytosis_2|Spherocytosis_type_3|not_specified|none_provided|not_provided	33	0.0
	H3-3A(3.6%)	exon4,c.344C>G,p.A115G	0.036	0.015	331|10	88|0	0.04444	430|20	1	226259113	226259113	C	G	panel_of_normals,strand_bias	H3-3A	NM_002107.7	4	c.344C>G	p.Ala115Gly	missense_variant				41	0.0
1	IDH1(0.0%)	exon4,c.395G>T,p.R132L	0.0003434	0.003983	3925|4	1182|8	0.01010	8426|86	2	209113112	209113112	C	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	20	0.0
1	IDH1(0.1%)	exon4,c.394C>T,p.R132C	0.001021	0.00112	3926|4	1186|0	0.00183	7620|14	2	209113113	209113114	G	A	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	36	0.0
1	IDH1(0.0%)	exon4,c.394C>G,p.R132G	0.0003434	0.00112	3926|3	1186|0	0.00522	7620|40	2	209113113	209113114	G	C	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>G	p.Arg132Gly	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	26	0.0
1	IDH1(0.0%)	exon4,c.394C>A,p.R132S	0.0004226	0.004871	3926|6	1186|7	0.00742	7620|57	2	209113113	209113114	G	T	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>A	p.Arg132Ser	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	43	0.0
	ANO10(4.1%)	exon2,c.132del,p.D45fs	0.041	0.06	1649|80	269|17	0.04499	3354|158	3	43647212	43647213	CT	C	normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia	43	0.0
	ATR(5.8%)	exon10,c.2320del,p.I774fs	0.058	0.058	4513|335	1544|113	0.05401	12768|729	3	142274739	142274740	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	44	0.0
	ATR(1.4%)	exon10,c.2320dup,p.I774fs	0.014	0.021	4513|111	1544|53	0.02853	12768|375	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	39	0.0
	PIK3CA(16.4%)	exon2,c.310C>T,p.P104S	0.164	0.001237	2731|546	1126|0	0.15427	6562|1197	3	178916923	178916923	C	T	PASS	PIK3CA	NM_006218.4	2	c.310C>T	p.Pro104Ser	missense_variant				40	0.0
1	PIK3CA(0.2%)	exon10,c.1633G>A,p.E545K	0.001635	0.004447	4069|7	657|2	0.00068	10316|7	3	178936091	178936092	G	A	clustered_events,normal_artifact,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>A	p.Glu545Lys	missense_variant	Pathogenic/Likely_pathogenic		Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Segmental_undergrowth_associated_with_lymphatic_malformation|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Sarcoma|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Carcinoma_of_gallbladder|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Gallbladder_cancer|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|Eccrine_Angiomatous_Hamartoma|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	50	0.0
1	PIK3CA(0.0%)	exon10,c.1633G>C,p.E545Q	0.000346	0.002221	4069|3	657|1	0.00213	10316|22	3	178936091	178936092	G	C	clustered_events,normal_artifact,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>C	p.Glu545Gln	missense_variant	Pathogenic/Likely_pathogenic,_drug_response		Histone_Methylation_Therapy_response|Hepatocellular_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Head_and_Neck_Neoplasms|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	32	0.0
1	PIK3CA(0.0%)	exon10,c.1634A>C,p.E545A	0.0003498	0.00225	4066|11	656|1	0.00201	10446|21	3	178936092	178936092	A	C	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>C	p.Glu545Ala	missense_variant	Pathogenic		Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	60	0.0
1	PIK3CA(0.0%)	exon10,c.1634A>T,p.E545V	0.0003453	0.002223	4066|3	656|0	0.00105	10446|11	3	178936092	178936092	A	T	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>T	p.Glu545Val	missense_variant	Pathogenic		Breast_neoplasm|Neoplasm_of_the_large_intestine	63	0.0
1	KIT(0.1%)	exon11,c.1669T>A,p.W557R	0.0008352	0.000923	6036|7	1656|1	0.00323	17262|56	4	55593603	55593603	T	A	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>A	p.Trp557Arg	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	36	0.0
	KIT(0.0%)	exon11,c.1669T>G,p.W557G	0.0004243	0.0008491	6036|8	1656|6	0.00524	17262|91	4	55593603	55593603	T	G	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>G	p.Trp557Gly	missense_variant	Likely_pathogenic		Gastrointestinal_stromal_tumor	39	0.0
1	KIT(0.1%)	exon11,c.1676T>G,p.V559G	0.0005469	0.001143	5939|36	1614|20	0.01711	16833|293	4	55593610	55593610	T	G	base_qual,clustered_events,orientation,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	35	0.0
1	KIT(0.0%)	exon17,c.2460T>G,p.D820E	0.0002692	0.004159	5445|4	344|0	0.00322	16098|52	4	55599334	55599334	T	G	base_qual,strand_bias,weak_evidence	KIT	NM_000222.3	17	c.2460T>G	p.Asp820Glu	missense_variant	Pathogenic		Thymoma	31	0.0
-	APC(13.2%)	exon16,c.3956del,p.P1319fs	0.132	0.021	575|84	59|0	0.13437	831|129	5	112175245	112175246	TC	T	PASS	APC	NM_000038.6	16	c.3956del	p.Pro1319fs	frameshift_variant	Pathogenic		Familial_adenomatous_polyposis_1|Malignant_Colorectal_Neoplasm|not_provided	41	0.0
	RAD50(4.4%)	exon13,c.2165del,p.K722fs	0.044	0.042	9132|545	2728|160	0.04874	41023|2102	5	131931451	131931452	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	45	0.0
	RAD50(1.1%)	exon13,c.2165dup,p.E723fs	0.011	0.012	9132|167	2728|58	0.02401	41023|1009	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	44	0.0
	TTK(2.0%)	exon22,c.2560del,p.R854fs	0.02	0.056	1587|47	24|0	0.02053	3482|73	6	80751896	80751897	GA	G	multiallelic,panel_of_normals,slippage	TTK	NM_003318.5	22	c.2560del	p.Arg854fs	frameshift_variant				34	0.0
	TTK(2.3%)	exon22,c.2560dup,p.R854fs	0.023	0.056	1587|47	24|0	0.03492	3482|126	6	80751896	80751897	GA	GAA	multiallelic,panel_of_normals,slippage	TTK	NM_003318.5	22	c.2560dup	p.Arg854fs	frameshift_variant				42	0.0
1	EGFR(0.1%)	exon18,c.2125G>C,p.E709Q	0.0006919	0.001135	3681|3	1269|1	0.00166	7235|12	7	55241677	55241677	G	C	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2125G>C	p.Glu709Gln	missense_variant				44	0.0
1	EGFR(0.1%)	exon18,c.2126A>C,p.E709A	0.0005928	0.001132	3639|5	1257|0	0.00181	7170|13	7	55241678	55241678	A	C	base_qual,clustered_events,normal_artifact,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2126A>C	p.Glu709Ala	missense_variant	Uncertain_significance		Lung_carcinoma|not_specified	38	0.0
1	EGFR(0.1%)	exon18,c.2152C>G,p.L718V	0.0009561	0.001404	2777|4	932|0	0.00233	5148|12	7	55241704	55241704	C	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2152C>G	p.Leu718Val	missense_variant				24	0.0
1	EGFR(0.2%)	exon18,c.2170G>A,p.G724S	0.001666	0.002165	2291|4	755|1	0.00119	4194|5	7	55241722	55241722	G	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2170G>A	p.Gly724Ser	missense_variant	Uncertain_significance		Neoplasm_of_the_large_intestine|not_specified	26	0.0
1	EGFR(0.0%)	exon19,c.2235_2249del,p.E746_A750del	0.000187	0.0005916	7801|3	2533|0	0.00000	15170|0	7	55242464	55242479	AGGAATTAAGAGAAGC	A	base_qual,clustered_events,position,weak_evidence	EGFR	NM_005228.5	19	c.2235_2249del	p.Glu746_Ala750del	disruptive_inframe_deletion	drug_response		Tyrosine_kinase_inhibitor_response	0	0.0
1	EGFR(0.1%)	exon20,c.2386G>C,p.G796R	0.000765	0.00251	1906|3	576|0	0.00166	3001|5	7	55249088	55249088	G	C	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2386G>C	p.Gly796Arg	missense_variant				62	0.0
1	EGFR(0.1%)	exon20,c.2389T>G,p.C797G	0.0007802	0.002603	1890|6	558|2	0.00477	3131|15	7	55249091	55249091	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>G	p.Cys797Gly	missense_variant				44	0.0
1	EGFR(0.1%)	exon21,c.2572C>A,p.L858M	0.001182	0.004922	2941|9	910|6	0.00448	4667|21	7	55259514	55259514	C	A	base_qual,clustered_events,normal_artifact,orientation,weak_evidence	EGFR	NM_005228.5	21	c.2572C>A	p.Leu858Met	missense_variant	Uncertain_significance		Non-small_cell_lung_carcinoma|not_specified	43	0.0
1	EGFR(0.1%)	exon21,c.2573T>G,p.L858R	0.001081	0.004039	2917|23	892|8	0.00851	4776|41	7	55259515	55259515	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	52	0.0
1	EGFR(0.1%)	exon21,c.2582T>A,p.L861Q	0.0008776	0.001683	2834|3	873|0	0.00194	4635|9	7	55259524	55259524	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2582T>A	p.Leu861Gln	missense_variant	Pathogenic/Likely_pathogenic,_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Tyrosine_kinase_inhibitor_response	46	0.0
1	MET(0.1%)	exon14,c.2888-1G>A	0.0005457	0.0009476	7395|5	1371|0	0.00092	25959|24	7	116411902	116411902	G	A	orientation,strand_bias,weak_evidence	MET	NM_000245.4	13	c.2888-1G>A		splice_acceptor_variant&intron_variant				51	0.0
1	MET(0.0%)	exon14,c.3007T>A,p.Y1003N	0.0004422	0.0008867	7505|7	1617|0	0.00167	33410|56	7	116412022	116412022	T	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3007T>A	p.Tyr1003Asn	missense_variant				42	0.0
1	MET(0.0%)	exon14,c.3008A>T,p.Y1003F	0.0003219	0.0008831	7576|7	1637|2	0.00331	33735|112	7	116412023	116412023	A	T	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>T	p.Tyr1003Phe	missense_variant				24	0.0
1	MET(0.0%)	exon14,c.3028G>C,p.D1010H	0.0001843	0.0008586	7603|4	1672|7	0.00103	34086|35	7	116412043	116412043	G	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>C	p.Asp1010His	missense_variant&splice_region_variant				42	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0004061	0.0008512	7603|17	1672|4	0.01082	34086|373	7	116412043	116412043	G	T	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				32	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.0005604	0.001688	7619|5	1679|2	0.00067	34342|23	7	116412044	116412044	G	A	clustered_events,normal_artifact,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	52	0.0
1	MET(0.0%)	exon14,c.3028+1G>T	0.0001923	0.000846	7619|5	1679|1	0.00423	34342|146	7	116412044	116412044	G	T	clustered_events,normal_artifact,weak_evidence	MET	NM_000245.4	14	c.3028+1G>T		splice_donor_variant&intron_variant	risk_factor		Osteofibrous_dysplasia|not_provided	56	0.0
1	MET(0.0%)	exon14,c.3028+2T>C	0.0004228	0.000846	7556|3	1669|0	0.00056	34092|19	7	116412045	116412045	T	C	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+2T>C		splice_donor_variant&intron_variant	not_provided		not_provided	0	0.0
0	BRAF(0.0%)	exon15,c.1803A>C,p.K601N	0.0002643	0.001729	5663|4	852|1	0.00379	13682|52	7	140453132	140453136	T	G	base_qual,clustered_events,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1803A>C	p.Lys601Asn	missense_variant	Uncertain_significance		Melanoma|B-cell_chronic_lymphocytic_leukemia|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Adenocarcinoma_of_prostate|Rasopathy|Malignant_neoplasm_of_body_of_uterus	30	0.0
	BRAF(0.0%)	exon15,c.1802A>T,p.K601I	0.0003788	0.001724	5667|3	851|1	0.00331	13866|46	7	140453133	140453136	T	A	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1802A>T	p.Lys601Ile	missense_variant	Likely_pathogenic		Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	14	0.0
1	BRAF(0.1%)	exon15,c.1801A>G,p.K601E	0.0005856	0.001706	5650|3	854|0	0.00043	13969|6	7	140453134	140453136	T	C	clustered_events,weak_evidence	BRAF	NM_004333.6	15	c.1801A>G	p.Lys601Glu	missense_variant	Pathogenic		Neoplasm|Melanoma|B-cell_chronic_lymphocytic_leukemia|Thyroid_cancer,_nonmedullary,_2|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Malignant_neoplasm_of_body_of_uterus	40	0.0
0	BRAF(0.1%)	exon15,c.1799T>G,p.V600G	0.000723	0.00171	4738|6	840|0	0.00431	13862|60	7	140453136	140453139	A	C	clustered_events	BRAF	NM_004333.6	15	c.1799T>G	p.Val600Gly	missense_variant	Pathogenic		Melanoma|Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	25	0.0
	BRAF(0.0%)	exon15,c.1799T>C,p.V600A	0.0002906	0.00171	4738|4	840|1	0.00022	13862|3	7	140453136	140453139	A	G	clustered_events	BRAF	NM_004333.6	15	c.1799T>C	p.Val600Ala	missense_variant	Likely_pathogenic		Melanoma	14	0.0
1	BRAF(15.9%)	exon15,c.1799T>A,p.V600E	0.159	0.00171	4738|826	840|0	0.15501	13862|2543	7	140453136	140453139	A	T	clustered_events	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic,_drug_response,_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stromal_tumor|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Colorectal_cancer|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Germ_cell_tumor,_nonseminomatous|Astrocytoma,_low-grade,_somatic|not_provided	41	0.0
1	BRAF(0.0%)	exon15,c.1798G>C,p.V600L	0.0002621	0.00173	5618|3	840|0	0.00153	16927|26	7	140453137	140453137	C	G	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1798G>C	p.Val600Leu	missense_variant	Pathogenic		Melanoma|Cardiofaciocutaneous_syndrome_1	39	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.0006392	0.001762	5594|5	820|0	0.00095	16825|16	7	140453139	140453139	G	A	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	58	0.0
-	KMT2C(1.5%)	exon38,c.8390dup,p.E2798fs	0.015	0.017	6750|137	2250|59	0.02876	19888|589	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,panel_of_normals	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	41	0.0
	KMT2C(3.9%)	exon14,c.2185A>G,p.N729D	0.039	0.04	337|10	28|0	0.03125	434|14	7	151945334	151945334	T	C	panel_of_normals,strand_bias	KMT2C	NM_170606.3	14	c.2185A>G	p.Asn729Asp	missense_variant				19	0.0
	MYC(7.5%)	exon2,c.296G>A,p.G99E	0.075	0.1	57|4	9|0	0.05263	72|4	8	128750759	128750759	G	A	PASS	MYC	NM_002467.6	2	c.296G>A	p.Gly99Glu	missense_variant				7	0.0
	SKIDA1(8.0%)	exon4,c.1283_1285del,p.E428del	0.08	0.038	80|6	31|0	0.05594	135|8	10	21805466	21805469	CCCT	C	panel_of_normals,slippage	SKIDA1	NM_207371.4	4	c.1283_1285del	p.Glu428del	disruptive_inframe_deletion				49	0.0
	RET(0.4%)	exon10,c.1796C>A,p.P599H	0.004395	0.003792	1305|7	409|1	0.00718	2351|17	10	43609040	43609040	C	A	PASS	RET	NM_020975.6	10	c.1796C>A	p.Pro599His	missense_variant	Uncertain_significance		Multiple_endocrine_neoplasia,_type_2	59	0.0
	RET(0.0%)	exon11,c.1900T>A,p.C634S	0.0004217	0.001072	3824|4	1214|1	0.00304	12776|39	10	43609948	43609948	T	A	clustered_events,orientation,strand_bias,weak_evidence	RET	NM_020975.6	11	c.1900T>A	p.Cys634Ser	missense_variant	Pathogenic		Multiple_endocrine_neoplasia,_type_2	37	0.0
	RET(9.0%)	exon14,c.2430C>T,p.G810=	0.09	0.058	63|5	16|0	0.07317	76|6	10	43615016	43615016	C	T	PASS	RET	NM_020975.6	14	c.2430C>T	p.Gly810=	synonymous_variant				20	0.0
1	RET(0.0%)	exon16,c.2753T>C,p.M918T	0.0001278	0.0003799	12196|5	3886|0	0.00014	43891|6	10	43617416	43617416	T	C	base_qual,orientation,strand_bias,weak_evidence	RET	NM_020975.6	16	c.2753T>C	p.Met918Thr	missense_variant	Pathogenic/Likely_pathogenic		Gingival_overgrowth|Hypertelorism|Hypothyroidism|Joint_hypermobility|Short_stature|Tetralogy_of_Fallot|Constipation|Pheochromocytoma|Medullary_thyroid_carcinoma|Thick_vermilion_border|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Hirschsprung_disease_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Multiple_endocrine_neoplasia,_type_2|Inborn_genetic_diseases|Thyroid_carcinoma,_sporadic_medullary|not_specified|not_provided	43	0.0
	CD3G(3.8%)	exon3,c.213del,p.K71fs	0.038	0.044	1825|81	394|19	0.03711	3477|134	11	118220582	118220583	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Immunodeficiency_17	38	0.0
	CD3G(1.4%)	exon3,c.213dup,p.W72fs	0.014	0.016	1825|32	394|11	0.01696	3477|60	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	43	0.0
	CBL(4.9%)	exon9,c.1380_1382del,p.D460del	0.049	0.041	174|8	38|0	0.04262	292|13	11	119149355	119149358	TATG	T	panel_of_normals,slippage	CBL	NM_005188.4	9	c.1380_1382del	p.Asp460del	disruptive_inframe_deletion	Uncertain_significance		Noonan_syndrome-like_disorder_with_or_without_juvenile_myelomonocytic_leukemia|Rasopathy	31	0.0
1	KRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0006296	0.001725	5555|11	1732|3	0.00415	20898|87	12	25378562	25378562	C	A	normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	4	c.436G>T	p.Ala146Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Uncertain_significance(1)	Rasopathy|not_provided	31	0.0
1	KRAS(0.1%)	exon4,c.436G>A,p.A146T	0.0005201	0.001801	5555|4	1732|2	0.00038	20898|8	12	25378562	25378562	C	T	normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Uncertain_significance		OCULOECTODERMAL_SYNDROME,_SOMATIC|Neoplasm_of_the_large_intestine|not_provided	53	0.0
1	KRAS(0.0%)	exon3,c.181C>A,p.Q61K	0.0002825	0.0006902	5353|4	2187|1	0.00390	17886|70	12	25380277	25380277	G	T	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.181C>A	p.Gln61Lys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	4	0.0
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.000977	0.00134	5107|6	2072|4	0.00441	16497|73	12	25380283	25380283	C	A	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided	29	0.0
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0007548	0.002106	5107|3	2072|4	0.00067	16497|11	12	25380283	25380283	C	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	50	0.0
1	KRAS(0.0%)	exon2,c.38G>T,p.G13V	0.0002722	0.0004814	7675|8	3025|2	0.00469	25236|119	12	25398281	25398282	C	A	base_qual,clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|not_provided	34	0.0
1	KRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0001854	0.0004946	7661|4	3021|4	0.00484	26087|127	12	25398282	25398282	C	A	clustered_events,normal_artifact,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_large_intestine|RAS-associated_autoimmune_leukoproliferative_disorder|not_provided	37	0.0
1	KRAS(0.0%)	exon2,c.37G>C,p.G13R	0.0002	0.0004809	7661|4	3021|0	0.00111	26087|29	12	25398282	25398282	C	G	clustered_events,normal_artifact,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>C	p.Gly13Arg	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Pilocytic_astrocytoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|not_provided	52	0.0
1	KRAS(0.1%)	exon2,c.37G>A,p.G13S	0.0006124	0.0009581	7661|5	3021|2	0.00065	26087|17	12	25398282	25398282	C	T	clustered_events,normal_artifact,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>A	p.Gly13Ser	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	30	0.0
1	KRAS(0.0%)	exon2,c.35G>T,p.G12V	0.0001865	0.0007687	7657|10	3016|2	0.00423	25869|110	12	25398284	25398285	C	A	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.35G>T	p.Gly12Val	missense_variant	Pathogenic		Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_pancreas|not_provided	18	0.0
1	KRAS(0.0%)	exon2,c.34G>T,p.G12C	0.0001878	0.0005325	7652|3	3010|4	0.00451	26058|118	12	25398285	25398285	C	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>T	p.Gly12Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Pathogenic(7),Uncertain_significance(1)	Endometrial_carcinoma|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Gallbladder_cancer|not_provided	26	0.0
1	KRAS(0.0%)	exon2,c.34G>A,p.G12S	0.0004778	0.0009643	7652|4	3010|2	0.00058	26058|15	12	25398285	25398285	C	T	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Gastric_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|not_provided	26	0.0
	PHGR1(8.9%)	exon4,c.135_200del,p.P46_P67del	0.089	0.032	202|6	55|0	0.00000	88|0	15	40648314	40648380	ACTGCGGGCCACCCCCTGGCCATGGCCCAGGGCCCTGCGGGCCACCCCCCCACCATGGTCCAGGGCC	A	panel_of_normals,slippage	PHGR1	NM_001145643.2	4	c.135_200del	p.Pro46_Pro67del	disruptive_inframe_deletion				30	0.0
	BLM(1.4%)	exon7,c.1544dup,p.N515fs	0.014	0.015	11688|234	4619|96	0.02481	56139|1428	15	91304138	91304138	G	GA	multiallelic,normal_artifact,panel_of_normals	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	41	0.0
	CHD2(4.1%)	exon33,c.4173dup,p.Q1392fs	0.041	0.017	286|13	66|0	0.03421	480|17	15	93545433	93545433	G	GA	panel_of_normals,slippage	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3),Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizures|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	29	0.0
-	CDH1(0.4%)	exon3,c.259del,p.R87fs	0.004411	0.005258	11888|70	4284|27	0.00461	42324|196	16	68835664	68835665	CA	C	normal_artifact,panel_of_normals	CDH1	NM_004360.5	3	c.259del	p.Arg87fs	frameshift_variant	Pathogenic		Hereditary_diffuse_gastric_cancer	36	0.0
	TP53(11.6%)	exon6,c.584T>A,p.I195N	0.116	0.0009989	3768|505	1408|0	0.11919	8225|1113	17	7578265	7578265	A	T	PASS	TP53	NM_000546.6	6	c.584T>A	p.Ile195Asn	missense_variant	Uncertain_significance		Hepatocellular_carcinoma|Acute_myeloid_leukemia|B-cell_chronic_lymphocytic_leukemia|Pancreatic_adenocarcinoma|Multiple_myeloma|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Hereditary_cancer-predisposing_syndrome|Glioblastoma|Li-Fraumeni_syndrome	38	0.0
	NOTCH3(12.2%)	exon29,c.5265G>T,p.L1755=	0.122	0.125	30|4	6|0	0.10526	34|4	19	15278157	15278157	C	A	orientation	NOTCH3	NM_000435.3	29	c.5265G>T	p.Leu1755=	synonymous_variant				40	0.0
	POLR1G(12.5%)	exon3,c.1306G>A,p.E436K	0.125	0.077	55|7	11|0	0.11392	70|9	19	45912532	45912532	G	A	PASS	POLR1G	NM_012099.3	3	c.1306G>A	p.Glu436Lys	missense_variant				15	0.0
	PPP2R1A(10.7%)	exon13,c.1580G>A,p.R527H	0.107	0.092	51|5	12|0	0.09836	55|6	19	52725413	52725413	G	A	PASS	PPP2R1A	NM_014225.6	13	c.1580G>A	p.Arg527His	missense_variant				52	0.0
	C21orf58(17.8%)	exon8,c.894_896del,p.H299del	0.178	0.125	29|5	8|0	0.11321	47|6	21	47721985	47721988	ATGG	A	germline,panel_of_normals,slippage	C21orf58	NM_058180.5	8	c.894_896del	p.His299del	disruptive_inframe_deletion				39	0.0
	GGT1(2.9%)	exon13,c.1283G>A,p.S428N	0.029	0.024	267|10	56|0	0.06471	318|22	22	25023893	25023893	G	A	PASS	GGT1	NM_001288833.2	13	c.1283G>A	p.Ser428Asn	missense_variant				58	0.0
	GGT1(3.0%)	exon13,c.1305A>G,p.V435=	0.03	0.027	229|8	45|0	0.06863	285|21	22	25023915	25023915	A	G	panel_of_normals	GGT1	NM_001288833.2	13	c.1305A>G	p.Val435=	synonymous_variant				41	0.0
	AR(6.7%)	exon1,c.1597G>A,p.G533R	0.067	0.145	85|5	8|0	0.05155	92|5	X	66766585	66766585	G	A	PASS	AR	NM_000044.6	1	c.1597G>A	p.Gly533Arg	missense_variant				56	0.0
